Rounds were small this week, with no round crossing the $200 million barrier. One has to wonder if we may be seeing some Silicon Valley Bank fallout.
Health, Wellness & Biotech
Despite the millions of venture dollars poured into the biotech sector, the costs and challenges of scaling keep startups from becoming the next big...
For seed-funded startups, the odds of graduating to a Series A round have never been particularly favorable. But as venture funding contracts, the...
Spark Capital certainly came in like a lion this March, leading a $300 million round for AI startup Anthropic, and co-leading Adept AI's Series B.
Flare Therapeutics raised $123 million in Series B funding to power its clinical trial to delve into its oncology program.
Artera, which uses artificial intelligence for cancer testing and personalized care, raised a $90 million round to support the distribution of its...
Another San Francisco-based AI company came in near the top of this week's list. Investors seem to have blinders on for AI startups right now, so...
Health care and life sciences startups relied heavily on Silicon Valley Bank, and its demise may force a shift to more traditional banks.
SVB was an active pillar in the biotech community, and its downfall leaves life sciences companies particularly vulnerable.
The big news of the week in venture obviously is not who raised what but rather where will they put that money? Nevertheless, there were some big...
Given the notoriously awful performance of so many SPAC mergers, you’d think new deals wouldn’t be happening. But you would be wrong — we are still...
67.1K Followers